-
-
-
-
-
-
-
Citizens Downgrades Foghorn Therapeutics (FHTX) to Market Perform
-
-
-
-
-
-
-
Foghorn Therapeutics Inc. (FHTX) Misses Q1 EPS by 1c
-
-
-
-
-
-
-
Jefferies Assumes Foghorn Therapeutics (FHTX) at Buy
-
-
-
-
-
-
-
Foghorn Therapeutics to present ARID1B degrader data at summit
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Foghorn Therapeutics (FHTX)
-
-
-
-
-
-
-
Foghorn Therapeutics (FHTX) says efficacy threshold not achieved to support continued development of FHD-286
-
-
-
-
-
-
-
GSK (GSK) and Flagship Pioneering partner to discover novel medicines and vaccines
479,047 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


